Guided Therapeutics INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

OQB

31 Mar 2025

GTHP

10-K: Guided Therapeutics Faces Going Concern Uncertainty Despite Efforts to Secure FDA Approval and Expand Internationally

Guided Therapeutics' 10-K filing reveals ongoing financial challenges and efforts to commercialize its LuViva cervical cancer detection device while pursuing regulatory approvals and strategic partnerships.

OQB

28 Mar 2024

GTHP

Guided Therapeutics INC

10-K: Guided Therapeutics Reports 2023 Financial Results, Focuses on LuViva Commercialization

Guided Therapeutics, a medical technology company, released its 2023 annual report, highlighting its focus on commercializing the LuViva cervical cancer detection device and navigating financial challenges.